<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comments on: Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent To Be Superior To The Standard Of Care For Breakthrough Cancer Pain</title>
	<atom:link href="http://discusspharmacy.com/2009/11/archimedes-pharma-announces-ground-breaking-phase-iii-data-showing-nasalfent-to-be-superior-to-the-standard-of-care-for-breakthrough-cancer-pain/feed/" rel="self" type="application/rss+xml" />
	<link>http://discusspharmacy.com/2009/11/archimedes-pharma-announces-ground-breaking-phase-iii-data-showing-nasalfent-to-be-superior-to-the-standard-of-care-for-breakthrough-cancer-pain/</link>
	<description>Blog for discussing pharmacy drugs and new developments in pharmacy</description>
	<pubDate>Tue, 16 Mar 2010 01:18:43 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	</channel>
</rss>
